Dr. Amit Mishra is a Professor at the Department of
Bioscience & Bioengineering, Indian Institute of Technology, Jodhpur,
Rajasthan, India. He obtained his Ph.D. in Neuroscience from the National Brain
Research Centre in 2008. He is a Fellow of the Royal Society of Medicine, UK, a
Fellow of the Indian Academy of Neuroscience, and a recipient of more than 37
National and International Scientific Awards. His research is mainly focused on
cellular and molecular neurobiology, cell cycle regulation, and cancer. He has
published more than 124 research articles in peer-reviewed journals and 4 book
chapters.
Dr. Kamla Kant Shukla is an Additional Professor at the Department of
Biochemistry, All India Institute of Medical Sciences, India. He obtained his
Ph.D. in Biochemistry from King George’s Medical University in 2010 and
completed a postdoctoral fellowship at Chung-Ang University in 2012. His
research program is focused on translational genomics and proteomics. A major
area of his current research is understanding the role of noncoding RNAs in the
regulation of androgen receptor signaling in reproductive and cancer biology
and developing biomarkers and new modalities for its treatment. He has
published more than 35 research papers in reputed journals in reproductive and
cancer biology and has also written a book. He is also a Life Member of the
Association of Reproductive Health Professionals, USA, the Association of
Clinical Biochemists of India, the Indian Academy of Biomedical Sciences
(IABS), and an Associate Member of the Royal Society of Biology.
Dr. Ashok Kumar is a Professor at the Department of Biochemistry, All India Institute of Medical
Sciences (AIIMS), Bhopal, India. He obtained his B.Sc. from Rohilkhand University, Bareilly, India, in 1997, and his M.Sc. in Molecular Biology and Biotechnology from GBPUAT, Pantnagar, India, in
2000, and his Ph.D. from Sanjay Gandhi Postgraduate Institute of Medical
Sciences (SGPGIMS), Lucknow, India in 2006. He then worked as a Postdoctoral Fellow at
the Texas A&M Health Science Centre, Temple, TX, USA, from December 2006 to
August 2007. From September 2007 to June 2012, he served as a Senior Postdoctoral Fellow at the UCSF-Benioff's Children’s Hospital Oakland and Research Centre, Oakland, CA, USA. He joined AIIMS Bhopal in September 2012. He is also a Life Member of the Indian Association for Cancer
Research, the Indian Society of Translational Research, and an Active Member of
the American Association for Cancer Research. He is a Fellow of the Royal Society of Biology (FRSB), London. His research interests are sphingolipid signaling, cancer biology, and tumor immunology. He is an Associate Editor of Frontiers in Molecular Biosciences and Guest Editor of Frontiers in Immunology.
Naveen Dutt received his MD in Pulmonary Medicine from the Government Medical College & Hospital, Chandigarh, India. He is a Professor in the Department of Pulmonary Medicine, All India Institute of Medical Sciences Jodhpur, India. He specialized in pulmonary medicine. His interests include interstitial lung diseases, transplant pulmonology, and sleep medicine.
Dr. Dinesh Kumar Ahirwar is an Assistant Professor in the Department of
Bioscience & Bioengineering, Indian Institute of Technology Jodhpur, India.
He is also a Research Assistant Professor in the Department of Pathology,
Wexner Medical Center, The Ohio State University, USA. He obtained his B.Sc.
from Devi Ahilya Vishwavidyalaya in 2003, his M.Sc. from Devi Ahilya
Vishwavidyalaya in 2005, and his Ph.D. from Sanjay Gandhi Postgraduate
Institute of Medical Sciences in 2010. He completed his post-doctoral training
at the School of Medicine, University of Utah, USA. His major research focus is understanding how tumor cells hijack surrounding stromal cells, including
fibroblasts, endothelial cells, and immune cells, to acquire invasive and
metastatic properties. Using genetically modified and spontaneous tumor mouse
models, he has shown that the cancer-associated fibroblast-derived inflammatory
molecule CXCL12 enhances tumor cell intravasation by increasing vascular
permeability and leaky tumor vasculature expansion, resulting in lung metastasis. He utilizes pro/anti-inflammatory molecules to
develop immune-based strategies against aggressive and metastatic
tumors. He is also a member of the American Association for Cancer Research and
the International Association for the Study of Lung Cancer, USA.
